Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.54 - $1.82 $20,821 - $70,177
-38,559 Reduced 29.99%
90,000 $153,000
Q3 2023

Nov 14, 2023

SELL
$0.97 - $1.8 $14,679 - $27,239
-15,133 Reduced 10.53%
128,559 $132,000
Q2 2023

Aug 14, 2023

SELL
$1.11 - $2.88 $16,465 - $42,721
-14,834 Reduced 9.36%
143,692 $167,000
Q1 2023

May 15, 2023

SELL
$1.51 - $3.25 $4,196 - $9,031
-2,779 Reduced 1.72%
158,526 $239,000
Q4 2022

Feb 14, 2023

SELL
$2.25 - $4.67 $8,313 - $17,255
-3,695 Reduced 2.24%
161,305 $403,000
Q3 2022

Nov 14, 2022

BUY
$2.66 - $5.37 $343,948 - $694,362
129,304 Added 362.24%
165,000 $696,000
Q2 2022

Aug 15, 2022

SELL
$2.3 - $6.29 $16,403 - $44,860
-7,132 Reduced 16.65%
35,696 $100,000
Q1 2022

May 16, 2022

BUY
$4.63 - $9.94 $1,518 - $3,260
328 Added 0.77%
42,828 $245,000
Q4 2021

Feb 14, 2022

BUY
$8.35 - $12.6 $181,670 - $274,138
21,757 Added 104.89%
42,500 $388,000
Q3 2021

Nov 15, 2021

BUY
$10.13 - $15.0 $4,599 - $6,810
454 Added 2.24%
20,743 $222,000
Q2 2021

Aug 16, 2021

BUY
$13.27 - $18.48 $13,057 - $18,184
984 Added 5.1%
20,289 $315,000
Q1 2021

May 14, 2021

SELL
$14.49 - $20.72 $11,447 - $16,368
-790 Reduced 3.93%
19,305 $313,000
Q4 2020

Feb 16, 2021

SELL
$14.61 - $22.14 $74,817 - $113,378
-5,121 Reduced 20.31%
20,095 $425,000
Q3 2020

Nov 16, 2020

SELL
$13.67 - $17.77 $58,562 - $76,126
-4,284 Reduced 14.52%
25,216 $374,000
Q2 2020

Aug 14, 2020

SELL
$10.89 - $21.47 $15,137 - $29,843
-1,390 Reduced 4.5%
29,500 $434,000
Q1 2020

May 15, 2020

SELL
$10.23 - $24.56 $11,355 - $27,261
-1,110 Reduced 3.47%
30,890 $363,000
Q4 2019

Feb 14, 2020

BUY
$17.42 - $26.61 $383,240 - $585,420
22,000 Added 220.0%
32,000 $752,000
Q2 2019

Aug 14, 2019

BUY
$16.93 - $26.22 $169,300 - $262,200
10,000 New
10,000 $186,000

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $184M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.